Evidence map›Paper›PMID 39885916›Full record

ArticleExperimental and therapeutic medicine2025

Unveiling a pathogenic

Idalid Cuero-Quezada, Sinhue Alejandro Brukman-Jiménez, Alfredo Corona-Rivera, Jorge Román Corona-Rivera, María Magdalena Ortiz-Sandoval, Leonardo Juárez-Zucco, Fernando Alexis Flores-Leura, Felipe De Jesús Bustos-Rodríguez, Lucina Bobadilla-Morales

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Idalid Cuero-QuezadaHuman Genetics PhD Program, Department of Molecular Biology and Genomics, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco 44340, México.
Sinhue Alejandro Brukman-JiménezCytogenetics Unit, Hospital Civil de Guadalajara Dr Juan I. Menchaca, Guadalajara, Jalisco 44340, México.
Alfredo Corona-RiveraHuman Genetics Institute 'Dr Enrique Corona Rivera', Department of Molecular Biology and Genomics, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco 44340, México.
Jorge Román Corona-RiveraCenter for Registry and Research in Congenital Anomalies, Service of Genetics, Pediatrics Division, Hospital Civil de Guadalajara Dr Juan I. Menchaca, Guadalajara, Jalisco 44340, México.
María Magdalena Ortiz-SandovalTransplant Unit of Hematopoietic Progenitor Cells, Pediatric Hematology and Oncology Department, Hospital Civil de Guadalajara Dr Juan I. Menchaca, Guadalajara, Jalisco 44340, México.
Leonardo Juárez-ZuccoInnovation and Research Department, University of Advanced Technologies, Zapopan, Jalisco 45050, México.
Fernando Alexis Flores-LeuraHuman Genetics PhD Program, Department of Molecular Biology and Genomics, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco 44340, México.
Felipe De Jesús Bustos-RodríguezDepartment of Anatomy and Pathology, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Jalisco 44340, México.
Lucina Bobadilla-MoralesHuman Genetics Institute 'Dr Enrique Corona Rivera', Department of Molecular Biology and Genomics, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco 44340, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fanconi anemia (FA) is the most common hereditary bone marrow failure syndrome, with an incidence of 1 in 5,000,000. This disease is caused by an alteration in one of the 23 genes associated with the FA/BRCA DNA repair pathway, which is responsible for repairing interstrand bridges generated during homologous recombination. FA has been associated with a predisposition to other types of neoplasm. The current study aimed to present a pathogenic variant in

Indexed as

FANCAFanconi anemiaMexican familypathogenic variant

Identifiers

PMID39885916
PMCPMC11775750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.